Cognition Therapeutics Inc
CGTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$80.2M
Close$
$0.50
50.8% downside
Current Fair Value
50.8% downsideOvervalued by 50.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $80.20 Million |
|---|---|
| Enterprise Value | $49.57 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 1.75 |
| Outstanding Shares | 89,191,313 |
Return
| Return on Equity | -50.17% |
|---|---|
| Return on Assets | -41.52% |
| Return on Invested Capital | -142.39% |
Valuation & Multiples
| P/E Ratio | -4.16 |
|---|---|
| PEG | 4.16 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.16 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$5.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.06%▼ 29.37% |
|---|---|
| Total Invested | $61,843▼ 99.62% |
| Investors Holding | 3▼ 72.00% |
ESG Score
No data